Rachel Sherman

Rachel E.
Sherman founded Rachel Sherman Partners LLC in 2019, where she is working as President from 2019.
Dr. Sherman also currently works at Mount Sinai Genomics, Inc., as Director from 2020, Eht Pharmacy LLC, as Independent Director from 2023, and Harvard Pilgrim Health Care, Inc., as Clinical Lecturer.
Dr. Sherman also formerly worked at Aptinyx, Inc., as Independent Director from 2019 to 2023, GeneDx Holdings Corp., as Independent Director from 2021 to 2023, and US Food & Drug Administration, as Principal Deputy Commissioner from 2017 to 2019.
Dr. Sherman received her undergraduate degree from Washington University in St. Louis, graduate degree from The Johns Hopkins University, and doctorate degree from Icahn School of Medicine at Mount Sinai.